In-silico method for elucidation of prodigiosin as PARP-1 inhibitor a prime target of Triple-negative breast cancer
Priya Sundararajan, Darjily Dharmaraj Rajaselvi, Suseela Vivekananthan, Shanmuga Priya Ramasamy
Topics & Concepts
ProdigiosinChemistryADMEIn silicoDocking (animal)Poly ADP ribose polymeraseDrugBiochemistryPharmacologyDNABiologyPolymeraseMedicineEscherichia coliNursingGeneIn vitroSerratia marcescensMicrobial Metabolism and ApplicationsComputational Drug Discovery MethodsTannin, Tannase and Anticancer Activities